FRA:MED - Deutsche Boerse Ag - DE0006595101 - Common Stock - Currency: EUR
FRA:MED (3/6/2025, 7:00:00 PM)
2.88
-0.02 (-0.69%)
The current stock price of MED.DE is 2.88 EUR. In the past month the price decreased by -5.26%. In the past year, price increased by 3.6%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
EMEIS.PA | EMEIS SA | 2.49 | 1.98B | ||
CLARI.PA | CLARIANE SE | N/A | 1.32B | ||
GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 1.15B | ||
RHK.DE | RHOEN-KLINIKUM AG | 19.25 | 863.78M | ||
GHC.MI | GAROFALO HEALTH CARE SPA | 13.08 | 448.29M | ||
M12.DE | M1 KLINIKEN AG | 17.41 | 290.67M | ||
LNA.PA | LNA SANTE | 11.32 | 283.81M | ||
LIK.DE | LIMES SCHLOSSKLINIKEN AG | N/A | 83.52M | ||
EIF.DE | MEDNATION AG | 1.32 | 4.21M |
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 6,882 full-time employees. The company went IPO on 2000-12-04. The firm is engaged in providing professional medical servies in the fields of acute care (acute segment) and rehabilitation (post-acute segment), as well as nursing care services, through its hospitals. The company focuses on a range of services in the acture and post-acute segments, such as: neurology, neurological early rehabilitation, neurosurgery, psychosomatics and psychiatry, geriatrics, as well as orthopaedics. Other areas of special competencies are: tinnitus, cochlea implants and internal medicine (cardiology, pneumology, edocrinology), as well as the treatment of post- and long-COVID-19 symptoms.
MEDICLIN AG
Okenstr. 27
Offenburg BADEN-WUERTTEMBERG DE
Employees: 6910
Company Website: https://www.mediclin.de/
Investor Relations: http://www.mediclin.de/en/investor-relations/financial-publications
Phone: 497814880
The current stock price of MED.DE is 2.88 EUR. The price decreased by -0.69% in the last trading session.
The exchange symbol of MEDICLIN AG is MED and it is listed on the Deutsche Boerse Ag exchange.
MED.DE stock is listed on the Deutsche Boerse Ag exchange.
6 analysts have analysed MED.DE and the average price target is 4.36 EUR. This implies a price increase of 51.41% is expected in the next year compared to the current price of 2.88. Check the MEDICLIN AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MEDICLIN AG (MED.DE) has a market capitalization of 136.80M EUR. This makes MED.DE a Micro Cap stock.
MEDICLIN AG (MED.DE) currently has 6910 employees.
MEDICLIN AG (MED.DE) has a support level at 2.87 and a resistance level at 2.98. Check the full technical report for a detailed analysis of MED.DE support and resistance levels.
The Revenue of MEDICLIN AG (MED.DE) is expected to grow by 0.09% in the next year. Check the estimates tab for more information on the MED.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MED.DE does not pay a dividend.
MEDICLIN AG (MED.DE) will report earnings on 2025-04-30.
MEDICLIN AG (MED.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.23).
ChartMill assigns a technical rating of 7 / 10 to MED.DE. When comparing the yearly performance of all stocks, MED.DE is one of the better performing stocks in the market, outperforming 76.77% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to MED.DE. MED.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months MED.DE reported a non-GAAP Earnings per Share(EPS) of -0.23. The EPS decreased by -154.78% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1.23% | ||
ROE | -5.26% | ||
Debt/Equity | 2 |
ChartMill assigns a Buy % Consensus number of 83% to MED.DE. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 352% and a revenue growth 0.09% for MED.DE